{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:56:27Z","timestamp":1751608587617,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008628","name":"Ministry of Electronics and Information Technology","doi-asserted-by":"crossref","award":["13(2)-2015-CC-BT"],"award-info":[{"award-number":["13(2)-2015-CC-BT"]}],"id":[{"id":"10.13039\/501100008628","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NWO research grant","award":["629.002.205"],"award-info":[{"award-number":["629.002.205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lung cancer is the second most fatal disease worldwide. In the last few years, radiomics is being explored to develop prediction models for various clinical endpoints in lung cancer. However, the robustness of radiomic features is under question and has been identified as one of the roadblocks in the implementation of a radiomic-based prediction model in the clinic. Many past studies have suggested identifying the robust radiomic feature to develop a prediction model. In our earlier study, we identified robust radiomic features for prediction model development. The objective of this study was to develop and validate the robust radiomic signatures for predicting 2-year overall survival in non-small cell lung cancer (NSCLC). This retrospective study included a cohort of 300 stage I\u2013IV NSCLC patients. Institutional 200 patients\u2019 data were included for training and internal validation and 100 patients\u2019 data from The Cancer Image Archive (TCIA) open-source image repository for external validation. Radiomic features were extracted from the CT images of both cohorts. The feature selection was performed using hierarchical clustering, a Chi-squared test, and recursive feature elimination (RFE). In total, six prediction models were developed using random forest\u00a0(RF-Model-O, RF-Model-B), gradient boosting\u00a0(GB-Model-O, GB-Model-B), and support vector(SV-Model-O, SV-Model-B) classifiers to predict 2-year overall survival (OS) on original data as well as balanced data. Model validation was performed using 10-fold cross-validation, internal validation, and external validation. Using a multistep feature selection method, the overall top 10 features were chosen. On internal validation, the two\u00a0random forest models (RF-Model-O, RF-Model-B)\u00a0displayed the highest accuracy; their scores on the original and balanced datasets were 0.81 and 0.77\u00a0respectively. During external validation, both the random\u00a0forest\u00a0models\u2019 accuracy was 0.68. In our study,\u00a0robust radiomic features showed promising predictive performance to predict 2-year overall survival in NSCLC.<\/jats:p>","DOI":"10.1007\/s10278-023-00835-8","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:01:27Z","timestamp":1695322887000},"page":"2519-2531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival\u00a0in Non-Small-Cell Lung Cancer"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-3206","authenticated-orcid":false,"given":"Ashish Kumar","family":"Jha","sequence":"first","affiliation":[]},{"given":"Umeshkumar B.","family":"Sherkhane","sequence":"additional","affiliation":[]},{"given":"Sneha","family":"Mthun","sequence":"additional","affiliation":[]},{"given":"Vinay","family":"Jaiswar","sequence":"additional","affiliation":[]},{"given":"Nilendu","family":"Purandare","sequence":"additional","affiliation":[]},{"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[]},{"given":"Leonard","family":"Wee","sequence":"additional","affiliation":[]},{"given":"Venkatesh","family":"Rangarajan","sequence":"additional","affiliation":[]},{"given":"Andre","family":"Dekker","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"6","key":"835_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"835_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin."},{"key":"835_CR3","doi-asserted-by":"publisher","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA, editors. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. (2008) 83:584\u201394.\u00a0https:\/\/doi.org\/10.4065\/83.5.584","DOI":"10.4065\/83.5.584"},{"issue":"2","key":"835_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1148\/rg.2018170081","volume":"38","author":"BW Carter","year":"2018","unstructured":"Carter BW, Lichtenberger JP 3rd, Benveniste MK, et al. Revisions to the TNM staging of lung cancer: Rationale, significance, and clinical application. Radiographics. 2018;38(2):374\u2013391. https:\/\/doi.org\/10.1148\/rg.2018170081","journal-title":"Radiographics."},{"key":"835_CR5","doi-asserted-by":"publisher","unstructured":"Chu QS. Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion. Ther Adv Med Oncol. 2020;12:1758835919895756. Published 2020 Jan 23.\u00a0https:\/\/doi.org\/10.1177\/1758835919895756","DOI":"10.1177\/1758835919895756"},{"issue":"48","key":"835_CR6","doi-asserted-by":"publisher","first-page":"78985","DOI":"10.18632\/oncotarget.12587","volume":"7","author":"YL Zhang","year":"2016","unstructured":"Zhang YL, Yuan JQ, Wang KF, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016;7(48):78985\u201378993. https:\/\/doi.org\/10.18632\/oncotarget.12587","journal-title":"Oncotarget."},{"issue":"14","key":"835_CR7","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","volume":"21","author":"J Mendelsohn","year":"2003","unstructured":"Mendelsohn J, Baselga J. Status of epidermal growth factor receptorantagonists in the biology and treatment of cancer. J Clin Oncol. 2003; 21(14):2787\u20132799.","journal-title":"J Clin Oncol."},{"issue":"16","key":"835_CR8","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","volume":"290","author":"MG Kris","year":"2003","unstructured":"Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA. 2003;290(16):2149\u20132158","journal-title":"JAMA."},{"key":"835_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JOP.091065","volume":"6","author":"CG Azzoli","year":"2010","unstructured":"Azzoli CG, Giaccone G, Temin S. American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Oncol Pract 2010;6:39\u201343. https:\/\/doi.org\/10.1200\/JOP.091065","journal-title":"J Oncol Pract"},{"key":"835_CR10","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1200\/JCO.2002.10.112","volume":"20","author":"M Ranson","year":"2002","unstructured":"Ranson M, Hammond LA, Ferry D. et al. ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial. J Clin Oncol.2002;20:2240\u20132250.","journal-title":"J Clin Oncol."},{"issue":"2","key":"835_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images are more than pictures, they are data. Radiology. 2016;278(2):563\u2013577. https:\/\/doi.org\/10.1148\/radiol.2015151169","journal-title":"Radiology."},{"key":"835_CR12","doi-asserted-by":"publisher","unstructured":"R\u00e9v\u00e9sz D, Engelhardt EG, Tamminga JJ, et al. Decision support systems for incurable non-small cell lung cancer: a systematic review. BMC Med Inform Decis Mak. 2017;17(1):144. Published 2017 Oct 2. https:\/\/doi.org\/10.1186\/s12911-017-0542-1","DOI":"10.1186\/s12911-017-0542-1"},{"issue":"2","key":"835_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cllc.2015.11.007","volume":"17","author":"EP Gray","year":"2016","unstructured":"Gray EP, Teare MD, Stevens J, Archer R. Risk prediction models for lung cancer: A systematic review. Clin Lung Cancer. 2016;17(2):95\u2013106.","journal-title":"Clin Lung Cancer."},{"issue":"2","key":"835_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3348\/kjr.2019.0630","volume":"21","author":"G Lee","year":"2020","unstructured":"Lee G, Park H, Bak SH, Lee HY. Radiomics in lung cancer from basic to advanced: Current status and future directions. Korean J Radiol. 2020;21(2):159\u2013171. https:\/\/doi.org\/10.3348\/kjr.2019.0630","journal-title":"Korean J Radiol."},{"key":"835_CR15","doi-asserted-by":"publisher","unstructured":"Thawani R, Mustafa SA. The future of radiomics in lung cancer. Lancet Digit Health. 2020;2(3):e103.\u00a0https:\/\/doi.org\/10.1016\/S2589-7500(20)30022-4","DOI":"10.1016\/S2589-7500(20)30022-4"},{"issue":"10","key":"835_CR16","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/1759-7714.13163","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Kong C, Xu W, et al. Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature. Thorac Cancer. 2019;10(10):1904\u20131912. https:\/\/doi.org\/10.1111\/1759-7714.13163","journal-title":"Thorac Cancer."},{"key":"835_CR17","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"H Aerts","year":"2014","unstructured":"Aerts, H., Velazquez, E., Leijenaar, R. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5, 4006 (2014). https:\/\/doi.org\/10.1038\/ncomms5006","journal-title":"Nat Commun"},{"issue":"5","key":"835_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21147\/j.issn.1000-9604.2021.05.06","volume":"33","author":"L He","year":"2021","unstructured":"He L, Li Z, Chen X, et al. A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy. Chin J Cancer Res. 2021;33(5):592\u2013605.\u00a0https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2021.05.06","journal-title":"Chin J Cancer Res."},{"key":"835_CR19","doi-asserted-by":"publisher","unstructured":"Cong M, Yao H, Liu H, Huang L, Shi G. Development and evaluation of a venous computed tomography radiomics model to predict lymph node metastasis from non-small cell lung cancer. Medicine (Baltimore). 2020;99(18):e20074.\u00a0https:\/\/doi.org\/10.1097\/MD.0000000000020074","DOI":"10.1097\/MD.0000000000020074"},{"issue":"11","key":"835_CR20","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1002\/mp.13808","volume":"46","author":"I Tunali","year":"2019","unstructured":"Tunali I, Hall LO, Napel S, et al. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions. Med Phys. 2019;46(11):5075\u20135085. https:\/\/doi.org\/10.1002\/mp.13808","journal-title":"Med Phys."},{"key":"835_CR21","doi-asserted-by":"publisher","unstructured":"Jha AK, Mithun S, Jaiswar V, et al. Repeatability and reproducibility study of radiomic features on a phantom and human cohort. Sci Rep. 2021;11(1):2055. Published 2021 Jan 21. https:\/\/doi.org\/10.1038\/s41598-021-81526-8","DOI":"10.1038\/s41598-021-81526-8"},{"issue":"4","key":"835_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.05.053","volume":"102","author":"A Traverso","year":"2018","unstructured":"Traverso A, Wee L, Dekker A, Gillies R. Repeatability and reproducibility of radiomic features: A systematic review. Int J Radiat Oncol Biol Phys. 2018;102(4):1143\u20131158.\u00a0https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.053","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"835_CR23","doi-asserted-by":"publisher","DOI":"10.7937\/K9\/TCIA.2015.PF0M9REI","author":"HJWL Aerts","year":"2019","unstructured":"Aerts, H. J. W. L., Wee, L., Rios Velazquez, E., Leijenaar, R. T. H., Parmar, C., Grossmann, P. Lambin, P. (2019). Data From NSCLC-Radiomics [Data set]. The Cancer Imaging Archive. https:\/\/doi.org\/10.7937\/K9\/TCIA.2015.PF0M9REI","journal-title":"The Cancer Imaging Archive"},{"key":"835_CR24","unstructured":"Plastimatch V1.9.0 Software, Feb. 2022, [online] Available: https:\/\/sourceforge.net\/projects\/plastimatch\/."},{"key":"835_CR25","unstructured":"Pyradiomics Package V2.2.0, Feb. 2022, [online] Available: https:\/\/pyradiomics.readthedocs.io\/en\/latest\/."},{"key":"835_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani, C. et al. Global surveillance of cancer survival 1995 \u2013 2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385, 977\u20131010 (2015).","journal-title":"Lancet"},{"key":"835_CR27","doi-asserted-by":"publisher","unstructured":"He H, Bai Y, Garcia EA, Li S. ADASYN: Adaptive synthetic sampling approach for imbalanced learning. 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence), 2008, pp. 1322\u20131328.\u00a0https:\/\/doi.org\/10.1109\/IJCNN.2008.4633969.","DOI":"10.1109\/IJCNN.2008.4633969"},{"key":"835_CR28","doi-asserted-by":"publisher","first-page":"46349","DOI":"10.1038\/srep46349","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Oikonomou A, Wong A, et al. Radiomics-based prognosis analysis for non-small cell lung cancer. Sci Rep 2017;7:46349.","journal-title":"Sci Rep"},{"key":"835_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.compmedimag.2016.12.002","volume":"60","author":"D Paul","year":"2016","unstructured":"Paul D, Su R, Romain M, et al. Feature selection for outcome prediction in oesophageal cancer using genetic algorithm and random forest classifier. Comput Med Imaging Graph 2016;60:42\u201349.","journal-title":"Comput Med Imaging Graph"},{"key":"835_CR30","first-page":"82","volume":"14","author":"VP Singh","year":"2016","unstructured":"Singh VP, Srivastava A, Kulshreshtha D, et al. Mammogram classification using selected GLCM features and random forest classifier. Int J Comput Sci Inform Sec 2016;14:82\u201387","journal-title":"Int J Comput Sci Inform Sec"},{"key":"835_CR31","unstructured":"Feature selection, Feb., 2022, [online] https:\/\/www.omnisci.com\/technical-glossary\/feature-selection"},{"key":"835_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.18.00001","volume":"3","author":"S Walsh","year":"2019","unstructured":"Walsh S, de Jong EEC, van Timmeren JE, et al. Decision support systems in oncology. JCO Clin Cancer Inform. 2019;3:1\u20139.\u00a0https:\/\/doi.org\/10.1200\/CCI.18.00001","journal-title":"JCO Clin Cancer Inform."},{"key":"835_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.addr.2016.01.006","volume":"109","author":"P Lambin","year":"2017","unstructured":"Lambin P, Zindler J, Vanneste BG, et al. Decision support systems for personalized and participative radiation oncology. Adv Drug Deliv Rev. 2017;109:131\u2013153.\u00a0https:\/\/doi.org\/10.1016\/j.addr.2016.01.006","journal-title":"Adv Drug Deliv Rev."},{"issue":"1","key":"835_CR34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clcc.2017.06.007","volume":"17","author":"EG Engelhardt","year":"2018","unstructured":"Engelhardt EG, R\u00e9v\u00e9sz D, Tamminga HJ, et al.\u00a0Clinical usefulness of tools to support decision-making for palliative treatment of metastatic colorectal cancer: A systematic review. Clin Colorectal Cancer. 2018;17(1):e1\u2013e12.\u00a0https:\/\/doi.org\/10.1016\/j.clcc.2017.06.007","journal-title":"Clin Colorectal Cancer."},{"key":"835_CR35","doi-asserted-by":"publisher","unstructured":"Le VH, Kha QH, Hung TNK, Le NQK. Risk score generated from CT-based radiomics signatures for overall survival prediction in non-small cell lung cancer. Cancers (Basel). 2021;13(14):3616. Published 2021 Jul 19.\u00a0https:\/\/doi.org\/10.3390\/cancers13143616","DOI":"10.3390\/cancers13143616"},{"key":"835_CR36","doi-asserted-by":"publisher","unstructured":"Le VH, Kha QH, Minh TNT, Nguyen VH, Le VL, Le NQK. Development and validation of CT-based radiomics signature for overall survival prediction in multi-organ cancer [published online ahead of print, 2023 Jan 30]. J Digit Imaging. 2023.\u00a0https:\/\/doi.org\/10.1007\/s10278-023-00778-0","DOI":"10.1007\/s10278-023-00778-0"}],"container-title":["Journal of Digital Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-023-00835-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-023-00835-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-023-00835-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T21:52:45Z","timestamp":1702936365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-023-00835-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1007\/s10278-023-00835-8","relation":{},"ISSN":["0897-1889","1618-727X"],"issn-type":[{"type":"print","value":"0897-1889"},{"type":"electronic","value":"1618-727X"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}